We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.1B
AUM Growth
+$1.76B
Cap. Flow
+$154M
Cap. Flow %
0.81%
Top 10 Hldgs %
32.12%
Holding
703
New
28
Increased
257
Reduced
281
Closed
39

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$60.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$58.3M
3
SCHW
Charles Schwab
SCHW
+$54M
4
ABBV icon
AbbVie
ABBV
+$52.9M
5
PANW icon
Palo Alto Networks
PANW
+$42.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$92.7M
2
EMR icon
Emerson Electric
EMR
+$57.2M
3
MELI icon
Mercado Libre
MELI
+$48.9M
4
AVGO icon
Broadcom
AVGO
+$38.9M
5
MU icon
Micron Technology
MU
+$37.7M

Sector Composition

Rank Sector Weight
1 Technology 36.63%
2 Healthcare 23.08%
3 Financials 11.48%
4 Consumer Discretionary 7.78%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ULTA icon
201
Ulta Beauty
ULTA
$21.6B
$16.9M 0.09%
30,849
+6,118
+25% +$3.13M
WMS icon
202
Advanced Drainage Systems
WMS
$11.1B
$16.7M 0.09%
120,179
+25,909
+27% +$3.4M
ANET icon
203
Arista Networks
ANET
$211B
$16.6M 0.09%
113,815
-7,756
-6% -$999K
DXCM icon
204
DexCom
DXCM
$29.2B
$16.4M 0.09%
244,363
+199,908
+450% +$15.8M
BRKR icon
205
Bruker
BRKR
$9.44B
$16.3M 0.09%
501,679
-141,311
-22% -$5.04M
NTRA icon
206
Natera
NTRA
$36.6B
$16.1M 0.08%
99,814
CLH icon
207
Clean Harbors
CLH
$15.9B
$16M 0.08%
68,867
+18,367
+36% +$4.35M
XENE icon
208
Xenon Pharmaceuticals
XENE
$6.33B
$15.9M 0.08%
396,636
WCN
209
Waste Connections
WCN
$42.5B
$15.9M 0.08%
90,550
-68,124
-43% -$12.4M
ELV icon
210
Elevance Health
ELV
$83.2B
$15.9M 0.08%
49,258
-18,211
-27% -$5.66M
JXN icon
211
Jackson Financial
JXN
$8.59B
$15.6M 0.08%
154,403
+4,371
+3% +$408K
CAT icon
212
Caterpillar
CAT
$386B
$15.6M 0.08%
32,639
-4,471
-12% -$1.91M
T icon
213
AT&T
T
$170B
$15.2M 0.08%
536,520
-1,856
-0.3% -$52.7K
TTEK icon
214
Tetra Tech
TTEK
$8.62B
$14.9M 0.08%
447,729
-50,530
-10% -$1.84M
MTZ icon
215
MasTec
MTZ
$24.7B
$14.7M 0.08%
69,307
-95,190
-58% -$17.4M
IDXX icon
216
Idexx Laboratories
IDXX
$44.8B
$14.7M 0.08%
22,975
-56,053
-71% -$34M
ARQT icon
217
Arcutis Biotherapeutics
ARQT
$3.53B
$14.7M 0.08%
778,044
-12,391
-2% -$195K
STN icon
218
Stantec
STN
$8.2B
$14.5M 0.08%
134,844
-30,832
-19% -$3.37M
CVS icon
219
CVS Health
CVS
$139B
$14.4M 0.08%
190,958
-37,430
-16% -$2.57M
COF icon
220
Capital One
COF
$129B
$14.3M 0.07%
67,234
+1,718
+3% +$376K
SNDX icon
221
Syndax Pharmaceuticals
SNDX
$1.76B
$14.2M 0.07%
925,332
+250,247
+37% +$3.28M
WDAY icon
222
Workday
WDAY
$39.3B
$14M 0.07%
58,344
-45
-0.1% -$10.4K
ADBE icon
223
Adobe
ADBE
$101B
$13.9M 0.07%
39,541
-8,185
-17% -$2.94M
FERG icon
224
Ferguson
FERG
$44.9B
$13.9M 0.07%
61,882
+515
+0.8% +$117K
COGT icon
225
Cogent Biosciences
COGT
$6.81B
$13.7M 0.07%
954,209
+526,867
+123% +$6.24M

Similar funds

Candriam SCA's Q3 2025 Portfolio in Review

As of Q3 2025, Candriam SCA held 703 positions worth $19.1B, up 10% from $17.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q3 2025 filing shows 28 new, 257 increased, 281 reduced and 39 closed positions. Its largest new stake was Banco Macro: 322,600 shares worth $13.6M. The largest sale was NVIDIA, an estimated $92.7M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2025 buy was Banco Macro: 322,600 shares worth $13.6M.
  • Candriam SCA added most to Nu Holdings in Q3 2025, an estimated $60.7M increase.
  • Candriam SCA's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $92.7M.
  • Candriam SCA fully exited Verona Pharma in Q3 2025, selling an estimated $20.5M.
  • Candriam SCA's ten largest holdings make up 32% of its $19.1B portfolio in Q3 2025.
  • Candriam SCA opened 28 new positions and closed 39 in Q3 2025.
  • Candriam SCA's portfolio value rose 10% quarter-over-quarter to $19.1B.

Based on Candriam SCA's 13F filing for Q3 2025, filed 6 Nov 2025.